It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Differences in immune responses to viruses and autoimmune diseases such as systemic lupus erythematosus (SLE) can show sexual dimorphism. Age-associated B cells (ABC) are a population of CD11c+T-bet+ B cells critical for antiviral responses and autoimmune disorders. Absence of DEF6 and SWAP-70, two homologous guanine exchange factors, in double-knock-out (DKO) mice leads to a lupus-like syndrome in females marked by accumulation of ABCs. Here we demonstrate that DKO ABCs show sex-specific differences in cell number, upregulation of an ISG signature, and further differentiation. DKO ABCs undergo oligoclonal expansion and differentiate into both CD11c+ and CD11c− effector B cell populations with pathogenic and pro-inflammatory function as demonstrated by BCR sequencing and fate-mapping experiments. Tlr7 duplication in DKO males overrides the sex-bias and further augments the dissemination and pathogenicity of ABCs, resulting in severe pulmonary inflammation and early mortality. Thus, sexual dimorphism shapes the expansion, function and differentiation of ABCs that accompanies TLR7-driven immunopathogenesis.
Autoimmunity mediated by age-associated B cells (ABC) can affect males and females differently. Here, using a lupus-like mouse model that affects females more severely, the authors observe an ABC mediated and guanine nucleotide exchange factor (GEF) restrained pathogenic process involving TLR7.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details




1 Hospital for Special Surgery, Autoimmunity and Inflammation Program, New York, USA (GRID:grid.239915.5) (ISNI:0000 0001 2285 8823); Weill Cornell Medicine, Department of Microbiology and Immunology, New York, USA (GRID:grid.5386.8) (ISNI:000000041936877X)
2 Hospital for Special Surgery, Autoimmunity and Inflammation Program, New York, USA (GRID:grid.239915.5) (ISNI:0000 0001 2285 8823)
3 Perelman School of Medicine, Department of Pathology and Laboratory Medicine, Philadelphia, USA (GRID:grid.25879.31) (ISNI:0000 0004 1936 8972)
4 Hospital for Special Surgery, Research Division and Precision Medicine Laboratory, New York, USA (GRID:grid.239915.5) (ISNI:0000 0001 2285 8823)
5 Hospital for Special Surgery, Arthritis and Tissue Degeneration Program, New York, USA (GRID:grid.239915.5) (ISNI:0000 0001 2285 8823)
6 Hospital for Special Surgery, David Z. Rosensweig Genomics Research Center, New York, USA (GRID:grid.239915.5) (ISNI:0000 0001 2285 8823)
7 Hospital for Special Surgery, Department of Orthopedic Surgery, New York, USA (GRID:grid.239915.5) (ISNI:0000 0001 2285 8823)
8 Technische Universitat, Institute of Physiological Chemistry, Dresden, Germany (GRID:grid.4488.0) (ISNI:0000 0001 2111 7257)
9 Hospital for Special Surgery, Autoimmunity and Inflammation Program, New York, USA (GRID:grid.239915.5) (ISNI:0000 0001 2285 8823); Weill Cornell Medicine, Department of Microbiology and Immunology, New York, USA (GRID:grid.5386.8) (ISNI:000000041936877X); Hospital for Special Surgery, David Z. Rosensweig Genomics Research Center, New York, USA (GRID:grid.239915.5) (ISNI:0000 0001 2285 8823); Weill Cornell Medicine, Department of Medicine, New York, USA (GRID:grid.5386.8) (ISNI:000000041936877X)